XML 18 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 60,971 $ 29,754
Marketable securities, current 155,598 246,399
Accounts receivable 500 1,473
Prepaid expenses and other current assets 6,617 9,931
Total current assets 223,686 287,557
Marketable securities, non-current 29,857 60,962
Property and equipment, net 7,290 7,400
Right-of-use asset 65,520 70,116
Restricted cash 3,454 3,279
Other assets 3,206 1,526
Total assets 333,013 430,840
Current liabilities:    
Accounts payable 1,276 1,172
Accrued expenses and other current liabilities 15,484 19,769
Deferred revenue, current 8,424 16,618
Operating lease liability, current 5,087 4,700
Long-term debt − related party, current and net of discount 0 2,287
Total current liabilities 30,271 44,546
Deferred revenue, net of current 19,623 16,895
Operating lease liability, net of current 67,095 70,970
Long-term debt − related party, net of current and discount 0 9,195
Total liabilities 116,989 141,606
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of September 30, 2023 and December 31, 2022, respectively 0 0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 49,259,870 and 48,966,216 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 5 5
Additional paid-in capital 710,552 689,256
Accumulated other comprehensive loss (904) (4,137)
Accumulated deficit (493,629) (395,890)
Total stockholders’ equity 216,024 289,234
Total liabilities and stockholders’ equity $ 333,013 $ 430,840